104265-72-7

Upstream product

• 104206-01-1 (S)-4-Benzyloxymethoxy-2-methyl-pent-1-en-3-ol 
• 63296-56-0 (S)-(benzyloxymethoxy)propanal 
• 63296-55-9 (S)-(-) ethyl 2-<(benzyloxy)ymethoxy>propanoate 
• 104206-02-2 (S)-4-Benzyloxymethoxy-2-methyl-pent-1-en-3-one 
• 13291-18-4 isopropenylmagnesium bromide 

Downstream Products

• 104206-02-2 (S)-4-Benzyloxymethoxy-2-methyl-pent-1-en-3-one 
• 104206-10-2 (3R,4S,5R,6S)-2-Benzyloxymethoxy-4,6-dimethyl-oct-7-ene-3,5-diol 
• 104206-09-9 (2R,3S,4S,5R,6S)-2-((S)-1-Benzyloxymethoxy-ethyl)-6-iodomethyl-3,5-dimethyl-tetrahydro-pyran-4-ol 
• 104206-08-8 (2R,3S,4R,5R,6S)-2-((S)-1-Benzyloxymethoxy-ethyl)-6-hydroxymethyl-3,5-dimethyl-tetrahydro-pyran-4-ol 
• 104206-03-3 [(R)-1-((S)-1-Benzyloxymethoxy-ethyl)-2-methyl-allyloxy]-acetic acid 
• 104206-12-4 (5S,6S)-5-((S)-1-Benzyloxymethoxy-ethyl)-6-methyl-6-((E)-propenyl)-[1,4]dioxan-2-one 
• 104206-06-6 (2S,3R,6R)-6-((S)-1-Benzyloxymethoxy-ethyl)-3,5-dimethyl-3,6-dihydro-2H-pyran-2-carboxylic acid methyl ester 
• 104206-07-7 (2S,3R,4S,5S,6R)-6-((S)-1-Benzyloxymethoxy-ethyl)-4-hydroxy-3,5-dimethyl-tetrahydro-pyran-2-carboxylic acid methyl ester 
• 104206-04-4 [(R)-1-((S)-1-Benzyloxymethoxy-ethyl)-2-methyl-allyloxy]-acetic acid tert-butyl ester 
• 104206-05-5 ((1S,2S)-1-Acetyl-2-benzyloxymethoxy-propoxy)-acetic acid tert-butyl ester 
• 114826-10-7 (2S,3S)-2-[(4R,5S,6R)-6-((R)-2-Benzyloxy-1-methyl-ethyl)-2,2,5-trimethyl-[1,3]dioxan-4-yl]-pentane-2,3-diol 
• 114826-10-7 (2R,3R)-2-[(4R,5S,6R)-6-((R)-2-Benzyloxy-1-methyl-ethyl)-2,2,5-trimethyl-[1,3]dioxan-4-yl]-pentane-2,3-diol 
• 114826-13-0 (2S,3R)-2-[(4S,5R,6S)-2,2,5-Trimethyl-6-((S)-1-methyl-2-phenylsulfanyl-ethyl)-[1,3]dioxan-4-yl]-pentan-3-ol 
• 114846-93-4 3-Chloro-benzoic acid (2R,3R,4S,5R,6R)-3-benzyloxymethyl-4-(tert-butyl-dimethyl-silanyloxy)-6-((4R,5R)-5-ethyl-2,2,4-trimethyl-[1,3]dioxolan-4-yl)-5-methyl-tetrahydro-pyran-2-yl ester 

Relevant academic research and scientific papers

THE ESTER ENOLATE CLAISEN REARRANGEMENT. SYNTHESIS OF A C(1)-C(6) ERYTHRONOLIDE FRAGMENT

An enantioselective route to the C(1)-C(6) erythronolide unit 10 is described, involving the dioxanone-to-dihydropyran enolate Claisen rearrangement (78), regio- and stereoselective hydroboration to give 9a, and reductive fragmentation of the heterocyc